Immune-mediated Colitis
📧 Sign up to get email alerts when something new happens for Immune-mediated Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC) [Phase 2]
Phase 2 trial evaluating healthy-donor microbiome MTP-101-C for steroid-relapse/refractory immune-related adverse events and immune-mediated…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK Study [Phase 2]
Phase 2 TRICK study evaluating tofacitinib for refractory immune-related colitis from checkpoint inhibitor therapy; the trial status is term…
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Vedolizumab for Immune Mediated Colitis [Phase 2]
Phase 2 clinical trial update for vedolizumab in immune mediated colitis; current status is unknown.